EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 5

Valerian Valeriana officinalis L.

Also called: all-heal, garden heliotrope, valerian root

Valerian is a plant native to Europe and Asia that also grows in North America. It has been used medicinally since early Greek and Roman times. Its roots and rhizomes (underground stems) are used.

Category
Botanical
Part used
Roots and rhizomes
Strongest evidence
C Limited
Reviewed
2026-10-28

Class 1 Well studied in people. A 2020 systematic review and meta-analysis (J Evid Based Integr Med) found 40 articles on valerian as a single herb, 36 of them RCTs, and pooled 10 randomized placebo-controlled trials of repeated doses for subjective sleep quality. [5]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied3 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Valerian does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Valerian, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Sleep problemsCNCCIH calls the evidence inconsistent; the American Academy of Sleep Medicine's 2017 guideline recommended against valerian for chronic insomnia in adults. [1]
Anxiety disordersCCochrane (2006) found one 4-week pilot trial of 36 patients with generalized anxiety disorder: no significant difference from placebo; evidence insufficient for conclusions. [3]
Menopause symptomsCThree small studies suggest valerian might help, but NCCIH states the evidence is not enough to know. [1]
Depression, stress, PMS, menstrual crampsCNCCIH states there is not enough evidence to allow any conclusions. [1]

Main constituents: Valepotriates (iridoid esters) and volatile oils, including monoterpenes and sesquiterpenes, to which sedative effects are attributed [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Used with apparent safety at 300 to 600 milligrams daily for up to 6 weeks. [1]
  • Typical dosage is 300 to 600 mg at bedtime for sleep, or three times daily for stress. [2]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score C
    A: well known causeE: unlikely cause

    LiverTox likelihood score C (probable rare cause of clinically apparent liver injury), chapter updated 2020-04-05.

    Details and sources
  • Pregnancy and breastfeeding
    NCCIH: little is known about whether it is safe to use valerian during pregnancy or while breastfeeding.

    2 statements in the profile.

    Details and sources
  • Interactions with medicines
    5 listed

    Sedatives; CNS drugs (benzodiazepines, barbiturates); CYP2D6 and CYP3A4 substrates; Anesthesia; Medicinal products in general

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    1 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    EU (HMPC monograph EMA/HMPC/150848/2015 Corr. 1, dated 2 February 2016), well-established use for relief of mild nervous tension and sleep disorders, …

    Details and sources
  • Generally safe for short-term use by most adults; long-term safety is unknown. [1]
  • Possible headache, stomach upset, mental dullness, excitability, uneasiness and vivid dreams. Stopping abruptly after chronic use may cause withdrawal symptoms, rarely hallucinations. [1]
  • LiverTox likelihood score C (probable rare cause of clinically apparent liver injury), usually with other botanicals such as skullcap or black cohosh; onset 3 to 12 weeks, recovery within 2 to 4 months. [2]
  • Little is known about safety in pregnancy or breastfeeding. [1]
Interactions

Interactions

Known interactions of Valerian
WithWhat happens
Alcohol and sedativesShould not be taken together, because valerian might have a sleep-inducing effect. [1]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Regulation

Regulatory status

  • US: herbal products for oral use are often marketed as dietary supplements, which, unlike drugs, are not approved by the FDA before sale; manufacturers are responsible for safety and labeling. [1]
  • EU: an EU herbal monograph covers well-established use of a specific valerian root preparation for mild nervous tension and sleep disorders, and traditional use of other preparations for mild mental stress and sleep. [4]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Valepotriates, which with the volatile oils are believed to be the basis of the sedative effects Terpene alcohols [P1]
  • Volatile oils, including monoterpenes and sesquiterpenes Volatile (essential) oil: monoterpenes and sesquiterpenes [P1]
  • Valerenic acid (with hydroxyvalerenic and acetoxyvalerenic acid), used as a marker for quantitative analysis of valerian products Valerenic acids (marker compounds) [P2]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 1 entry naming valerian (Valeriana officinalis), as part of a multi-ingredient combination (NDI 506, submitted 2007-12-03). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P3]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of valerian was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P4]
  • NTP technical reports list checked 2026-10-29: no study of valerian root or its extracts. [P5]

Liver (NIH LiverTox)

  • LiverTox likelihood score C (probable rare cause of clinically apparent liver injury), chapter updated 2020-04-05. Published cases usually involved valerian combined with other botanicals; latency 3 to 12 weeks; usually mild to moderate with recovery within 2 to 4 months of stopping. [P1]

Interactions with medicines

  • Sedatives: NCCIH: valerian should not be taken along with sedatives because it might have a sleep-inducing effect. [P6]
  • CNS drugs (benzodiazepines, barbiturates): Animal and case data suggest additive effects; valerian prolonged pentobarbital-induced sleep in animal models. [P7]
  • CYP2D6 and CYP3A4 substrates: Valerian may inhibit CYP2D6 and CYP3A4, although other studies suggest CYP-mediated interactions are unlikely. [P7]
  • Anesthesia: MSK advises stopping valerian at least 1 week before surgery because of possible interactions with anesthesia. [P7]
  • Medicinal products in general: EU monograph: no interactions reported. [P8]

Alcohol

  • NCCIH: valerian should not be taken along with alcohol, because valerian might have a sleep-inducing effect. [P6]

Interactions with other herbs and supplements

  • Skullcap, black cohosh and other potentially hepatotoxic herbs: LiverTox notes that published liver-injury cases usually involved valerian combined with other botanicals such as skullcap or black cohosh, and that severe cases were usually associated with other potentially hepatotoxic herbals. [P1]

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination of each component that is a dietary ingredient — Required by 21 CFR 111.75(a)(1)(i) for every dietary-ingredient component; an exemption may be requested by petition under 21 CFR 10.30. [P9]
  • Conformity with the European Pharmacopoeia monograph for valerian root (Ph. Eur. 0453) — The EU herbal monograph states that the material complies with Ph. Eur. monograph 0453. [P8]
  • Valerenic acid assay (marker) — Valerenic acid is used as a marker for quantitative analysis of valerian products. [P2]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • In older women given valerian nightly, valerenic acid Cmax, Tmax, AUC, half-life and oral clearance did not differ significantly between a single dose and 2 weeks of dosing; inter- and intra-subject variability was considerable, and Cmax and AUC decreased and half-life increased with body weight. [P2]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • EU (HMPC monograph EMA/HMPC/150848/2015 Corr. 1, dated 2 February 2016), well-established use for relief of mild nervous tension and sleep disorders, adolescents, adults and elderly: single dose 400–600 mg dry extract (DER 3–7.4:1, ethanol 40–70% V/V), up to 3 times daily for nervous tension; for sleep, a single dose half to one hour before bedtime with an earlier dose during the evening if necessary; maximum 4 single doses daily; continued use over 2–4 weeks is stated for optimal effect. Traditional use (mild mental stress and to aid sleep): e.g. comminuted root 0.3–3 g per single dose (also as tea in 150 ml boiling water), with preparation-specific doses for other extracts and tinctures. Not recommended under 12 years. [P8]

Pregnancy and breastfeeding

  • NCCIH: little is known about whether it is safe to use valerian during pregnancy or while breastfeeding. [P6]
  • EU monograph: safety during pregnancy and lactation has not been established; in the absence of sufficient data, use is not recommended. [P8]

Sources for this profile

  1. NIH LiverTox (NIDDK). Valerian (Last Update: 2020-04-05), 2020-04-05. ncbi.nlm.nih.gov
  2. Anderson GD, et al. Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women. Phytother Res 2010;24(10):1442-6 (PMID 20878691), 2010-10. pubmed.ncbi.nlm.nih.gov
  3. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  4. IARC Monographs. Agents Classified by the IARC Monographs: List of Classifications (accessed 2026-10-29), 2026-10-29. monographs.iarc.who.int
  5. National Toxicology Program (NIEHS). Technical Reports list (accessed 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  6. NCCIH. Valerian: Usefulness and Safety (Last Updated: May 2025), 2025-05. nccih.nih.gov
  7. Memorial Sloan Kettering Cancer Center. About Herbs: Valerian (last updated November 21, 2023), 2023-11-21. mskcc.org
  8. European Medicines Agency, HMPC. European Union herbal monograph on Valeriana officinalis L., radix (EMA/HMPC/150848/2015 Corr. 1, dated 2 February 2016), 2016-02-02. ema.europa.eu
  9. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources

Sources

  1. NCCIH. Valerian: Usefulness and Safety (Last Updated: 2025-05), 2025-05. nccih.nih.gov
  2. NIH LiverTox (NIDDK). Valerian (Last Update: 2020-04-05), 2020-04-05. ncbi.nlm.nih.gov
  3. Cochrane Database of Systematic Reviews. Miyasaka LS, Atallah AN, Soares BG. Valerian for anxiety disorders. 2006;(4):CD004515 (PubMed abstract, PMID 17054208), 2006-10-18. pubmed.ncbi.nlm.nih.gov
  4. European Medicines Agency, HMPC. Valerianae radix (valerian root) - herbal medicinal product, 2026-03-11. ema.europa.eu
  5. Shinjyo N, Waddell G, Green J. Valerian root in treating sleep problems and associated disorders: a systematic review and meta-analysis. J Evid Based Integr Med 2020;25:2515690X20967323 (PMID 33086877), 2020-10-21. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.